US4756884A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Capillary flow device
Assignee: Roche Diagnostics Operations Inc
•
Filing: 1986-07-01
•
Granted: 1988-07-12
•
Expires: 2006-07-01
Abstract
Abstract Methods and devices are provided involving at least one chamber, at least one capillary, and at least one reagent involved in a system providing for a detectable signal. As appropriate, the devices provide for measuring a sample, mixing the sample with reagents, defining a flow path, and reading the result. Of particular interest is the use of combinations of specific binding pair members which result in agglutination information, where the resulting agglutination particles may provide for changes in flow rate, light patterns of a flowing medium, or light absorption or scattering. A fabrication technique particularly suited for forming internal chambers in plastic devices is also described along with various control devices for use with the device.
Inventors
- 👤 Robert S. Hillman
- 👤 Michael E. Cobb
- 👤 Jim Allen
- 👤 Ian Gibbons
- 👤 Vladimir Ostoich
- 👤 Laura J. Winfrey
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 20:26
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/483; G01N33/487; G01N33/49; G01N33/4905; B; B01; B01F; B01F25/00; B01F25/40; B01F25/42; B01F25/43; B01F25/431; B01F25/4316; B01F25/433; B01F25/4338; B01F33/00; B01F33/30; B01F35/00; B01F35/71; B01F35/717; B01F35/7172; B01L; B01L3/00; B01L3/50; B01L3/502; B01L3/5027; B01L3/50273; B01L3/502746; B29; B29C; B29C65/00; B29C65/02; B29C65/08; B29C66/00; B29C66/01; B29C66/05; B29C66/302; B29C66/3022; B29C66/30223; B29C66/50; B29C66/51; B29C66/54; B29C66/70; B29C66/71; G01N21/00; G01N21/75; G01N21/77; G01N21/82; B01F21/00; B01F2101/00; B01F2101/23; B01F23/00; B01F23/50; B01F23/56; B01L2200/00; B01L2200/06; B01L2200/0689; B01L2300/00; B01L2300/08; B01L2300/0809; B01L2300/0816; B01L2300/0861; B01L2300/0887; B01L2400/00; B01L2400/04; B01L2400/0403; B01L2400/0406; B01L2400/06; B01L2400/0694; B29C45/00; B29C59/00; B29C59/16; B29C65/48; B29C65/4895; B29C66/90; B29C66/95; B29C66/951; B29C66/9513; B29K; B29K2055/00; B29K2055/02; B29L; B29L2031/00; B29L2031/756; G01N15/00; G01N15/10; G01N15/1012; G01N2015/1016; G01N21/01; G01N21/03; G01N2021/0346; G01N35/00; G01N2035/00465; G01N2035/00514; G01N21/17; G01N21/47; G01N21/49; G01N33/50; G01N33/53; G01N33/543; G01N33/54366; Y; Y10; Y10S; Y10S366/00; Y10S366/03; Y10S435/00; Y10S435/81
Claims Analysis
Total Claims: 13
Claim 1
Independent Claim
138 words
An analytical device for detecting the presence of an analyte in a physiological fluid sample, comprising: a housing containing an inlet port, a chamber unit, an exit port, a first capillary unit for independently pumping a liquid from said inlet port to said chamber unit, and a second capillary unit positioned between and operatively connected to said chamber unit and said exit port for independently pumping a liquid from said chamber unit to said exit port; wherein said inlet port, first capillary unit, chamber unit, second capillary unit, and exit port are present in a continuous capillary pathway; said housing further containing a reagent in said capillary pathway comprising a member selected from the group consisting of compounds affecting blood clotting and antibodies capable of causing a change in flow rate of said fluid sample in said pathway.
Claim 2
Dependent Claim
138 words
An analytical device for detecting the presence of an analyte in a physiological fluid sample, comprising: a housing containing an inlet port, a chamber unit, an exit port, a first capillary unit for independently pumping a liquid from said inlet port to said chamber unit, and a second capillary unit positioned between and operatively connected to said chamber unit and said exit port for independently pumping a liquid from said chamber unit to said exit port; wherein said inlet port, first capillary unit, chamber unit, second capillary unit, and exit port are present in a continuous capillary pathway; said housing further containing a reagent in said capillary pathway comprising a member selected from the group consisting of compounds affecting blood clotting and antibodies capable of causing a change in flow rate of said fluid sample in said pathway.
Claim 3
Dependent Claim
11 words
The device of claim 1, wherein said reagent comprises an antibody.
Claim 4
Dependent Claim
17 words
The device of claim 1, wherein said device comprises at least two chamber units in said pathway.
Claim 5
Dependent Claim
26 words
The device of claim 1, further comprising a sealable vent in said capillary pathway proximal to a juncture between a chamber unit and a capillary unit.
Claim 6
Dependent Claim
26 words
The device of claim 1, further comprising a third capillary unit substantially in parallel with said first capillary unit and directing fluid into said chamber unit.
Claim 7
Dependent Claim
34 words
The device of claim 1, wherein said reagent comprises a member selected from the group consisting of components of natural blood clotting cascades and reagents which activate a components of a natural clotting cascade.
Claim 8
Dependent Claim
10 words
The device of claim 6, wherein said reagent is thromboplastin.
Claim 9
Dependent Claim
29 words
The device of claim 1, wherein said housing comprises a substantially hydrophobic material having at least a portion of the walls of said capillary pathway treated to provide hydrophilicity.
Claim 10
Dependent Claim
11 words
The device of claim 8, wherein said material is a plastic.
Claim 11
Dependent Claim
78 words
The device of claim 1, said device being fabricated from at least two sheets of a substantially hydrophobic plastic, at least one of which is molded to provide depressions for production of said capillary and chamber units, said depressions being treated to provide hydrophilicity, wherein at least one sheet has means defining an orifice forming said inlet port or exit port, said capillary and chamber units being formed by the joining of said sheets to form said housing.
Claim 12
Dependent Claim
40 words
The device of claim 10, wherein said chamber unit contains said reagent and said reagent comprises a member selected from the group consisting of components of natural clotting cascades and reagents which activate a component of a natural clotting cascade.
Claim 13
Dependent Claim
14 words
The device of claim 10, wherein said reagent comprises thromboplastin in said chamber unit.
References Cited (Backward Citations)
US3690836A
Cited
US3744975A
Cited
US3799742A
Cited
US3898982A
Cited
US3856470A
Cited
US3915644A
Cited
US3873217A
Cited
US3899296A
Cited
US3901658A
Cited
US4088448A
Cited
US4244916A
Cited
US4279862A
Cited
US4284602A
Cited
US4690899A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1991-07-12 | 1992-01-11 | 1992-07-12 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1995-07-12 | 1996-01-11 | 1996-07-12 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1999-07-12 | 2000-01-11 | 2000-07-12 | $7700.00 | Window Closed / Lapsed |